0001209191-17-058427.txt : 20171031 0001209191-17-058427.hdr.sgml : 20171031 20171031160845 ACCESSION NUMBER: 0001209191-17-058427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171030 FILED AS OF DATE: 20171031 DATE AS OF CHANGE: 20171031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alles Mark J CENTRAL INDEX KEY: 0001538897 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 171165805 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-30 0 0000816284 CELGENE CORP /DE/ CELG 0001538897 Alles Mark J C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 1 0 0 See Remarks Stock Option (right to buy) 100.97 2017-10-30 4 A 0 33881 A 2027-10-30 Common Stock 33881 33881 D Option is immediately exercisable and will vest in four equal annual installments, commencing on October 30, 2018. The option was issued pursuant to the Company's 2017 Stock Incentive Plan. Chief Executive Officer /s/ Peter N. Kellogg, Attorney-in-Fact 2017-10-31